PartnershipJul 14, 2026, 01:36 PM
Prenetics Secures $1B Growth Financing for IM8 Marketing
AI Summary
Prenetics Global Limited announced a $1 billion growth financing agreement with General Catalyst's Customer Value Fund for its AI-native wellness brand, IM8. This non-dilutive financing will fund up to 70% of IM8's marketing spend, with General Catalyst receiving a capped share of income tied to customer cohort performance. The company also raised IM8's full-year 2026 revenue guidance to $210–220 million and expects IM8 to reach $400 million or more in full-year 2027 revenue, accelerating its growth strategy.
Key Highlights
- Prenetics secured $1 billion in growth financing from General Catalyst's Customer Value Fund.
- General Catalyst will finance up to 70% of IM8's marketing spend.
- IM8 full-year 2026 revenue guidance raised to $210–220 million, up from $190–210 million.
- IM8 expected to reach $300 million in annualized run-rate revenue by year-end 2026.
- IM8 expected to deliver $400 million or more in full-year 2027 revenue.
- Every $1 invested in customer acquisition has returned $1.44 in gross profit.
- Prenetics had approximately $139.7 million in cash and financial assets as of May 31, 2026.
- IM8 recorded preliminary unaudited monthly revenue of approximately $17 million in June 2026.
Price Impact
More from PRE